Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Doranz

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Cell|March 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinNaveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Cell Host & Microbe|September 4, 2024
Erratum: Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya VirusScott A Smith, Laurie A Silva, Julie M Fox, et al.
Plos Neglected Tropical Diseases|September 27, 2013
A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from diseaseSuganya Selvarajah, Nicole R Sexton, Kristen M Kahle, et al.
Cell Reports|August 19, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Immunity|June 1, 2024
Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interfaceRachael M Wolters, James A Ferguson, Ivette A Nuñez, et al.
The Journal of Clinical Investigation|April 26, 2022
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimerNaveenchandra Suryadevara, Andrea R Shiakolas, Laura A VanBlargan, et al.
Cell Host & Microbe|July 11, 2015
Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya VirusScott A Smith, Laurie A Silva, Julie M Fox, et al.
Mabs|December 30, 2021
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage librariesTom Z Yuan, Pankaj Garg, Linya Wang, et al.
Nature Microbiology|May 9, 2018
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER regionAndrew I Flyak, Natalia Kuzmina, Charles D Murin, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Cell|March 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinNaveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Cell Host & Microbe|September 4, 2024
Erratum: Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya VirusScott A Smith, Laurie A Silva, Julie M Fox, et al.
Plos Neglected Tropical Diseases|September 27, 2013
A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from diseaseSuganya Selvarajah, Nicole R Sexton, Kristen M Kahle, et al.
Cell Reports|August 19, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Immunity|June 1, 2024
Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interfaceRachael M Wolters, James A Ferguson, Ivette A Nuñez, et al.
The Journal of Clinical Investigation|April 26, 2022
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimerNaveenchandra Suryadevara, Andrea R Shiakolas, Laura A VanBlargan, et al.
Cell Host & Microbe|July 11, 2015
Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya VirusScott A Smith, Laurie A Silva, Julie M Fox, et al.
Mabs|December 30, 2021
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage librariesTom Z Yuan, Pankaj Garg, Linya Wang, et al.
Nature Microbiology|May 9, 2018
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER regionAndrew I Flyak, Natalia Kuzmina, Charles D Murin, et al.
Pageof 10